Diabetes: Page 4

Roche H1 diagnostics revenues up 10% year over year
By LabPulse.com staff writers
The firm posted core laboratory revenues of CHF 3.88 billion, up 3% year-over-year from CHF 3.77 billion; point-of-care revenues of CHF 2.61 billion, up 45% year-over-year from CHF 1.80 billion; molecular laboratory revenues of CHF 1.98 billion, down 1% year-over-year from CHF 1.99 billion; diabetes care revenues for CHF 832 million, down 7% year-over-year from CHF 894 million; and pathology laboratory revenues of CHF 652 million, up 11% year-over-year from CHF 590 million.
July 20, 2022
2021 04 27 15 25 5437 Pathology Digital Workstation Microscope 400
GBS study compares glucose levels in saliva, blood
By LabPulse.com staff writers
The developer of a biosensor platform for point-of-care testing said it will now perform statistical analyses of the correlation of glucose levels among the sample types.
July 13, 2022
2022 05 27 20 42 7840 Doctor Lab Test Bipoc 400
Clinics begin adopting Genetic Technologies risk test
By LabPulse.com staff writers
The clinics can focus on testing for a single disease or multiple diseases, including breast cancer, colorectal cancer, ovarian cancer, coronary artery disease, prostate cancer, and type 2 diabetes, the company said.
June 30, 2022
2022 04 18 13 42 3384 Dna Genome Gene Targeted 400
Abbott to develop new glucose-ketone monitoring system
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation for the device, which will be the same size as the company's FreeStyle Libre 3 sensor, it said.
June 5, 2022
2021 09 27 23 55 5067 Diabetes Insulin Glucose Blood 400
LumiraDx diabetes test receives CE Mark
By LabPulse.com staff writers
The LumiraDx HbA1c test is used with the LumiraDx Platform for monitoring individuals with diabetes and provides results in less than seven minutes from sample application. The test is further used as an aid in screening and identifying patients who may be at risk for developing diabetes at the point of care, the company said.
June 1, 2022
2021 09 27 23 55 5067 Diabetes Insulin Glucose Blood 400
COVID-19 testing offers chance for diabetes screening, too
By Louise Gagnon
Study investigators hypothesized that they could leverage the existing COVID-19 testing infrastructure to also test for prediabetes and diabetes in a Latinx community that might otherwise face substantial barriers to care engagement.
May 26, 2022
2022 05 27 20 42 7840 Doctor Lab Test Bipoc 400
Levels launches on-demand blood testing service
By Leah Sherwood
The Metabolic Health Panel is currently available to all Levels members. Other lab tests include hemoglobin A1C, total cholesterol, low-density lipoprotein, cholesterol, high-density lipoprotein cholesterol, triglycerides, and high-sensitivity c-reactive protein.
March 28, 2022
2022 03 29 13 33 4058 2022 03 29 Levels 400
Know Labs approved for glucose monitoring clinical trial
By LabPulse.com staff writers
The trial will see blood glucose readings taken every five minutes for participants through a fingerstick device over a period of three to five hours. Participants will drink a glucola drink with 75 g of sugar, which should change their respective blood glucose levels. The Bio-RFID prototype will then measure these changes.
February 3, 2022
2022 02 04 16 47 2908 Sugar Drinks 400
Quest introduces personal health panel
By LabPulse.com staff writers
Quest's Comprehensive Health Profile is like a credit score for an individual's health, Quest said. The panel combines many of the tests and biometric screenings that a physician would typically order as part of an annual physical, such as a complete blood count, comprehensive metabolic panel, urinalysis, cardiovascular and diabetes risk assessment, plus others, such as inflammation, Quest said.
January 19, 2022
2020 04 02 20 02 8495 Quest Diagnostics 400
Diabetes testing market poised for growth
By Bruce Carlson
However, technological advances and increased knowledge of diabetes have led to two new areas driving the diabetes testing market: continuous glucose monitoring (CGM) and hemoglobin A1c (HbA1c) testing.
November 1, 2021
2021 09 27 23 55 5067 Diabetes Insulin Glucose Blood 400
Millions of diabetes blood tests missed during U.K. lockdown
By LabPulse.com staff writers
After extrapolating estimates from six laboratory testing centers across the U.K., researchers determined that approximately 2.5 million diagnostic diabetes blood tests -- an average of 400,000 each month -- were missed or delayed during the six-month lockdown in the U.K. These missed tests resulted in 23,000 missed prediabetes diagnoses and 68,500 missed diabetes diagnoses, according to the EASD.
September 26, 2021
2021 09 27 23 55 5067 Diabetes Insulin Glucose Blood 400
LifeScan, Cecelia Health to offer diabetes support
By LabPulse.com staff writers
Certified diabetes care and education specialists will offer telehealth through the OneTouch Reveal app, which will be fully integrated into the new portal OneTouch Solutions. In fall 2021, this will be offered to consumers in the U.S. In early 2022, it will be available as a reimbursed adjudicated option to healthcare providers and payors.
August 17, 2021
2021 08 18 21 58 1010 Diabetes Woman Lancet 400
Previous Page
Page 4 of 8
Next Page